サマリー

世界の原発性免疫不全治療薬市場 2022-2026 年
Technavioは、原発性免疫不全治療薬市場を監視しており、2022-2026年の間に31億3000万ドルの成長が見込まれ、予測期間中にCAGR7.73%で加速しています。当レポートでは、原発性免疫不全治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、免疫不全疾患の有病率の増加、小児における免疫疾患の発生率の上昇、遺伝子治療の技術的進歩によって牽引されています。
原発性免疫不全治療薬市場の分析には、疾患タイプセグメントと地理的展望が含まれます。
Technavioの一次免疫不全治療薬市場は、以下のように区分されています。
疾患タイプ別
- 抗体欠乏症
- 細胞性免疫不全
- 自然免疫障害
地理的状況別
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における主要な免疫不全治療薬市場の成長を促進する主な理由の1つとして、研究開発活動の増加を挙げています。また、遺伝子技術の進歩や免疫不全疾患に関する政府の啓発プログラムの増加も、同市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。原発性免疫不全治療薬市場に関する当レポートは、以下の分野を対象としています。
- 原発性免疫不全治療薬市場のサイジング
- 原発性免疫不全治療薬市場の予測
- 原発性免疫不全治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、ADMA Biologics Inc.を含むいくつかの主要な原発性免疫不全治療薬市場のベンダーに関する詳細な分析を提供します。アステラス製薬、バクスターインターナショナル、バイエル、Bio Products Laboratory Ltd.、バイオコン、Biotest AG、CSL Ltd.、Grifols SA、Kedrion Spa、LFB SA、ルパン、Octapharma AG、Pfizer Inc、Sankin、および武田薬品工業株式会社。Ltd.、オクタファーマ社、ファイザー社、サンキン社、武田薬品工業社などです。また、原発性免疫不全治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/primary-immunodeficiency-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Antibody deficiency - Market size and forecast 2021-2026
o Exhibit 28: Chart on Antibody deficiency - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Antibody deficiency - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Antibody deficiency - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Antibody deficiency - Year-over-year growth 2021-2026 (%)
o 5.4 Cellular immunodeficiency - Market size and forecast 2021-2026
o Exhibit 32: Chart on Cellular immunodeficiency - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Cellular immunodeficiency - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Cellular immunodeficiency - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Cellular immunodeficiency - Year-over-year growth 2021-2026 (%)
o 5.5 Innate immune disorders - Market size and forecast 2021-2026
o Exhibit 36: Chart on Innate immune disorders - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Innate immune disorders - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Innate immune disorders - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Innate immune disorders - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Disease Type
o Exhibit 40: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Bayer AG
o Exhibit 89: Bayer AG - Overview
o Exhibit 90: Bayer AG - Business segments
o Exhibit 91: Bayer AG - Key offerings
o Exhibit 92: Bayer AG - Segment focus
o 10.4 Bio Products Laboratory Ltd.
o Exhibit 93: Bio Products Laboratory Ltd. - Overview
o Exhibit 94: Bio Products Laboratory Ltd. - Product / Service
o Exhibit 95: Bio Products Laboratory Ltd. - Key offerings
o 10.5 Biocon Ltd.
o Exhibit 96: Biocon Ltd. - Overview
o Exhibit 97: Biocon Ltd. - Business segments
o Exhibit 98: Biocon Ltd. - Key offerings
o Exhibit 99: Biocon Ltd. - Segment focus
o 10.6 Biotest AG
o Exhibit 100: Biotest AG - Overview
o Exhibit 101: Biotest AG - Business segments
o Exhibit 102: Biotest AG - Key offerings
o Exhibit 103: Biotest AG - Segment focus
o 10.7 CSL Ltd.
o Exhibit 104: CSL Ltd. - Overview
o Exhibit 105: CSL Ltd. - Business segments
o Exhibit 106: CSL Ltd. - Key news
o Exhibit 107: CSL Ltd. - Key offerings
o Exhibit 108: CSL Ltd. - Segment focus
o 10.8 Grifols SA
o Exhibit 109: Grifols SA - Overview
o Exhibit 110: Grifols SA - Business segments
o Exhibit 111: Grifols SA - Key offerings
o Exhibit 112: Grifols SA - Segment focus
o 10.9 Kedrion Spa
o Exhibit 113: Kedrion Spa - Overview
o Exhibit 114: Kedrion Spa - Product / Service
o Exhibit 115: Kedrion Spa - Key offerings
o 10.10 Octapharma AG
o Exhibit 116: Octapharma AG - Overview
o Exhibit 117: Octapharma AG - Product / Service
o Exhibit 118: Octapharma AG - Key offerings
o 10.11 Pfizer Inc.
o Exhibit 119: Pfizer Inc. - Overview
o Exhibit 120: Pfizer Inc. - Product / Service
o Exhibit 121: Pfizer Inc. - Key news
o Exhibit 122: Pfizer Inc. - Key offerings
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 126: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Antibody deficiency - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Antibody deficiency - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Antibody deficiency - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Antibody deficiency - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Cellular immunodeficiency - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Cellular immunodeficiency - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Cellular immunodeficiency - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Cellular immunodeficiency - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Innate immune disorders - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Innate immune disorders - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Innate immune disorders - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Innate immune disorders - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Disease Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Bayer AG - Overview
Exhibits90: Bayer AG - Business segments
Exhibits91: Bayer AG - Key offerings
Exhibits92: Bayer AG - Segment focus
Exhibits93: Bio Products Laboratory Ltd. - Overview
Exhibits94: Bio Products Laboratory Ltd. - Product / Service
Exhibits95: Bio Products Laboratory Ltd. - Key offerings
Exhibits96: Biocon Ltd. - Overview
Exhibits97: Biocon Ltd. - Business segments
Exhibits98: Biocon Ltd. - Key offerings
Exhibits99: Biocon Ltd. - Segment focus
Exhibits100: Biotest AG - Overview
Exhibits101: Biotest AG - Business segments
Exhibits102: Biotest AG - Key offerings
Exhibits103: Biotest AG - Segment focus
Exhibits104: CSL Ltd. - Overview
Exhibits105: CSL Ltd. - Business segments
Exhibits106: CSL Ltd. - Key news
Exhibits107: CSL Ltd. - Key offerings
Exhibits108: CSL Ltd. - Segment focus
Exhibits109: Grifols SA - Overview
Exhibits110: Grifols SA - Business segments
Exhibits111: Grifols SA - Key offerings
Exhibits112: Grifols SA - Segment focus
Exhibits113: Kedrion Spa - Overview
Exhibits114: Kedrion Spa - Product / Service
Exhibits115: Kedrion Spa - Key offerings
Exhibits116: Octapharma AG - Overview
Exhibits117: Octapharma AG - Product / Service
Exhibits118: Octapharma AG - Key offerings
Exhibits119: Pfizer Inc. - Overview
Exhibits120: Pfizer Inc. - Product / Service
Exhibits121: Pfizer Inc. - Key news
Exhibits122: Pfizer Inc. - Key offerings
Exhibits123: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits124: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits125: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits126: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations